DATE: March 28, 2023
TO: Mayor and City Council
FROM: City Attorney
SUBJECT
Title
Adopt a Resolution Approving Participation in the National Opioid Settlement with Teva, Allergan, CVS, Walmart and Walgreens, Accepting the Terms of the California Allocation Agreement, and Authorizing the City Manager to Execute and Submit all Necessary Settlement Participation Documents on Behalf of the City of Hayward
End
RECOMMENDATION
Recommendation
That the Council adopts a resolution (Attachment II) approving participation in the National Opioid Settlement with Teva, Allergan, CVS, Walmart and Walgreens, accepting the terms of the California Allocation Agreement for each party, and authorizing the City Manager to execute and submit all necessary settlement participation documents on behalf of the City of Hayward.
End
SUMMARY
In November and December 2022, Teva, Allergan, Walmart, Walgreens and CVS entered into National Opioid Settlements arising out of coordinated national lawsuits against various responsible entities filed by various state attorneys general and various local subdivisions. On December 14, 2021, the City Council previously approved participation in settlements involving the three largest pharmaceutical opioid distributors: McKesson, Cardinal Health and AmerisourceBergen (“Distributors”), and opioid manufacturer Janssen Pharmaceuticals, Inc. and its parent company Johnson & Johnson (collectively, “J&J”). All of the settlements will provide substantial funds to states and subdivisions for abatement of the Opioids epidemic across the country and will impose transformative changes in the way the settling defendants conduct their business.
ATTACHMENTS
Attachment I Staff Report
Attachment II Resolution